Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer |
|
Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency |
|
Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis. |
|
Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair. |
|
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers |
|
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database |
|
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report |
|
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification |
|
Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer. |
|
Una mujer total, Matilde Hidalgo de Procel, 1980, i.e. 1981 (subj.) |
|
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. |
|
Organochlorine exposure and colorectal cancer risk. |
|
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
|
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report |
|
Telomere length and genetic anticipation in Lynch syndrome |
|
TP53, a gene for colorectal cancer predisposition in the absence of Li-Fraumeni-associated phenotypes |
|
Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment |
|